You are here

Programme at a Glance - 56th EASD Annual Meeting

Tuesday, 22 September 2020

 

Vienna Hall

Linz Hall

Graz Hall

Salzburg Hall

Innsbruck Hall

Klagenfurt Hall

08:40
08:45
Opening #EASD2020     
08:45
09:15
Presidential Address   
 
 
09:15
10:00
52nd Claude Bernard Lecture     
10:15
11:45
OP 1OP 2OP 3OP 4OP 5OP 6
12:00
13:00
Poster Event A
13:15
14:15
Poster Event B
14:30
16:00
OP 7OP 8OP 9OP 10OP 11OP 12
16:15
17:15
35th Camillo Golgi Lecture14th Albert Renold Lecture
16:55 - 17:55
    
17:15
17:55
     
18:10
19:10
     

EASD General Assembly

Wednesday, 23 September 2020

 

Vienna Hall

Linz Hall

Graz Hall

Salzburg Hall

Innsbruck Hall

Klagenfurt Hall

08:30
10:00
EASD/ADA Symposium: ADA/EASD Precision medicine in diabetes initiativeEASD/ESC Symposium: The dawn of CV risk reduction in type 2 diabetes: 5 years of SGLT2i CV outcome trialsSweet pregnancyHuman islet transcriptomes to gain insight into diabetes: promises and pitfallsThe LIBERATES Trial 

10:15
11:45

OP 13OP 14OP 15OP 16OP 17OP 18
12:00
13:00
Poster Event C
13:15
14:15
Poster Event D
14:30
16:00
OP 19OP 20OP 21OP 22OP 23OP 24
16:15
17:15
EASD-Novo Nordisk Foundation Diabetes Prize for Excellence     
17:30
18:30
What is the future of type 1 diabetes treatment?Diabetes in primary careVERTIS CV outcomeDiabetes and cancerMulti-dimensional roles of ketone bodies in fuel metabolism, signalling, and therapeuticsAn easy to digest guide to precision nutrition

Thursday, 24 September 2020

 

Vienna Hall

Linz Hall

Graz Hall

Salzburg Hall

Innsbruck Hall

Klagenfurt Hall

08:30
10:00
Diabetologia Symposium 2020: The pancreas in health and in diabetesAdvances in the pathogenesis and treatment of diabetic complications: going beyond the usualThe important conversation between the heart and the kidneyWe are what we do not eatRising Star Symposium
08:20 - 10:00
Empagliflozin for the treatment of chronic heart failure and a reduced ejection fraction in patients with and without diabetes: new results of the EMPEROR-Reduced trial
10:15
11:45
OP 25OP 26OP 27OP 28OP 29OP 30
12:00
13:00
Poster Event E

13:15
14:15

Poster Event F

14:30
16:00

OP 31OP 32OP 33OP 34OP 35OP 36
16:15
17:00

Induction of Honorary Members

55th Minkowski Lecture

     
17:15
18:15
Do we need surveillance of the liver of type 2 diabetes patients?New approaches to reducing hypoglycaemia: hype or hopeWhen your medicine gives you diabetesNew lessons about diabetic complications: 30 years and counting in the DCCT/EDICClosing the loop: commercial systems or open source? 

Friday, 25 September 2020

 

Vienna Hall

Linz Hall

Graz Hall

Salzburg Hall

Innsbruck Hall

Klagenfurt Hall

08:30
09:30

Comprehensive approaches with novel biomarkers for predicting purposesEASD/JDRF Symposium: Human iPSC-derived cells, the state-of-the-art to model diabetesTargeting the gut to treat diabetesUric acid: a biomarker or risk factor for disease - the answer is here!The role of altered lipid handling in diabetesMichael Berger Debate: ESC vs EASD/ADA-guidelines on diabetes and cardiovascular disease: Same evidence but different interpretations - who’s right?
09:45
10:45
OP 37OP 38OP 39OP 40OP 41OP 42
11:00
12:00
OP 43OP 44OP 45OP 46OP 47OP 48
12:15
13:45

Diabetes on the run: insulin therapy in type 1 diabetes and exercise

Innovative medicines initiative (IMI): the power of public private partnerships in diabetes researchAssessing the true burden of hypoglycaemiaA gender-sensitive approach pays off in diabetesEASD/AASD Symposium: Implementation science in diabetes 

 

Programme may be subject to change.

Non-commercial satellite symposia on the occasion of the 56th EASD Annual Meeting:

Tuesday,
22 Sept 2020

Novel biomarkers for type 2 diabetes
07:30 - 08:30, Lehár 1 Hall